Predictive approaches to guide the expression of recombinant vaccine targets in Escherichia coli: a case study presentation utilising Absynth Biologics Ltd. proprietary Clostridium difficile vaccine antigens.
- DOI
- 10.1007/s00253-021-11405-9
- Published
- 2021 Jul
- Container
- Applied microbiology and biotechnology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00253-021-11405-9,
title = {Predictive approaches to guide the expression of recombinant vaccine targets in Escherichia coli: a case study presentation utilising Absynth Biologics Ltd. proprietary Clostridium difficile vaccine antigens.},
author = {Hussain H and McKenzie EA and Robinson AM and Gingles NA and Marston F and Warwicker J and Dickson AJ},
year = {2021},
journal = {Applied microbiology and biotechnology},
doi = {10.1007/s00253-021-11405-9},
url = {https://doi.org/10.1007/s00253-021-11405-9}
}RIS
TY - JOUR TI - Predictive approaches to guide the expression of recombinant vaccine targets in Escherichia coli: a case study presentation utilising Absynth Biologics Ltd. proprietary Clostridium difficile vaccine antigens. AU - Hussain H AU - McKenzie EA AU - Robinson AM AU - Gingles NA AU - Marston F AU - Warwicker J AU - Dickson AJ PY - 2021 JO - Applied microbiology and biotechnology DO - 10.1007/s00253-021-11405-9 UR - https://doi.org/10.1007/s00253-021-11405-9 ER -
APA
H, H., EA, M., AM, R., NA, G., F, M., J, W., & AJ, D. (2021). Predictive approaches to guide the expression of recombinant vaccine targets in Escherichia coli: a case study presentation utilising Absynth Biologics Ltd. proprietary Clostridium difficile vaccine antigens.. Applied microbiology and biotechnology. https://doi.org/10.1007/s00253-021-11405-9
Source records
- pubmed · retrieved 2026-09-26T17:03:23.255Z